This is a Validated Antibody Database (VAD) review about mouse Snai2, based on 148 published articles (read how Labome selects the articles), using Snai2 antibody in all methods. It is aimed to help Labome visitors find the most suited Snai2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Snai2 synonym: Slug; Slugh; Snail2

Abcam
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 5j
  • western blot; human; loading ...; fig 5i
Abcam Snai2 antibody (Abcam, ab27568) was used in western blot on mouse samples (fig 5j) and in western blot on human samples (fig 5i). Cell Death Dis (2022) ncbi
domestic rabbit polyclonal
  • western blot; rat; loading ...; fig 3f
Abcam Snai2 antibody (Abcam, ab27568) was used in western blot on rat samples (fig 3f). Front Pharmacol (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 2e, 5e
Abcam Snai2 antibody (Abcam, ab27568) was used in western blot on human samples at 1:1000 (fig 2e, 5e). Front Oncol (2021) ncbi
mouse monoclonal (CL3700)
  • immunocytochemistry; human; loading ...; fig 5d
Abcam Snai2 antibody (Abcam, ab224731) was used in immunocytochemistry on human samples (fig 5d). Aging (Albany NY) (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; loading ...; fig s3b
Abcam Snai2 antibody (Abeam, ab180714) was used in immunohistochemistry on mouse samples (fig s3b). Cell Rep (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 6c
Abcam Snai2 antibody (Abcam, ab180714) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 6c). Genes (Basel) (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 8b
Abcam Snai2 antibody (Abcam, ab106077) was used in western blot on human samples (fig 8b). Aging (Albany NY) (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3a, 3c
Abcam Snai2 antibody (Abcam, ab27568) was used in western blot on human samples (fig 3a, 3c). Aging (Albany NY) (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; human; 1:100; loading ...; fig 6d
Abcam Snai2 antibody (Abcam, ab180714) was used in immunohistochemistry on human samples at 1:100 (fig 6d). Sci Adv (2020) ncbi
mouse monoclonal (mAbcam51772)
  • western blot; human; loading ...; fig s1d
Abcam Snai2 antibody (Abcam, ab51772) was used in western blot on human samples (fig s1d). BMC Cancer (2019) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; rat; 1:500; loading ...; fig 5f
  • western blot; rat; 1:1000; loading ...; fig 7b
Abcam Snai2 antibody (Abcam, ab27568) was used in immunohistochemistry - paraffin section on rat samples at 1:500 (fig 5f) and in western blot on rat samples at 1:1000 (fig 7b). EMBO Mol Med (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3b
Abcam Snai2 antibody (Abcam, ab106077) was used in western blot on human samples (fig 3b). Exp Ther Med (2019) ncbi
domestic rabbit polyclonal
  • western blot; dogs; loading ...; fig 6a
Abcam Snai2 antibody (Abcam, ab180714) was used in western blot on dogs samples (fig 6a). Nature (2018) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; loading ...; fig 10g
Abcam Snai2 antibody (abcam, ab27568) was used in immunohistochemistry on mouse samples (fig 10g). Dev Biol (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:100; fig 9d
  • western blot; human; 1:1000; loading ...; fig 3a
Abcam Snai2 antibody (Abcam, ab180714) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 9d) and in western blot on human samples at 1:1000 (fig 3a). Oncotarget (2017) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; loading ...; fig 4b
  • western blot; human; loading ...; fig 4a
Abcam Snai2 antibody (Abcam, ab27568) was used in immunocytochemistry on human samples (fig 4b) and in western blot on human samples (fig 4a). PLoS ONE (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 1i
Abcam Snai2 antibody (Abcam, ab27568) was used in western blot on human samples (fig 1i). Biosci Rep (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 2b
In order to test if chemotherapy affects the epithelial-mesenchymal transition of osteosarcoma cells, Abcam Snai2 antibody (Abcam, ab27568) was used in western blot on human samples at 1:1000 (fig 2b). Oncol Lett (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 4b
In order to test if chemotherapy affects the epithelial-mesenchymal transition of osteosarcoma cells, Abcam Snai2 antibody (Abcam, ab180714) was used in western blot on human samples at 1:1000 (fig 4b). Oncol Lett (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; fig 2e
In order to find that CDH6 is expressed in the oviduct and is repressed by mutant p53, Abcam Snai2 antibody (Abcam, ab106077) was used in western blot on mouse samples at 1:1000 (fig 2e). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 3
Abcam Snai2 antibody (abcam, ab180714) was used in western blot on human samples (fig 3). Cancer Gene Ther (2016) ncbi
domestic rabbit polyclonal
  • western blot; rat; fig 6
Abcam Snai2 antibody (Abcam, ab180714) was used in western blot on rat samples (fig 6). Evid Based Complement Alternat Med (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 4
  • western blot; human; fig 4
In order to study promotion of epithelial-mesenchymal transition in human renal tubular epithelial cell via glioma-associated oncogene homolog 1, Abcam Snai2 antibody (Abcam, ab180714) was used in western blot on mouse samples (fig 4) and in western blot on human samples (fig 4). Am J Transl Res (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:75; fig 2
In order to study clear cell renal cell carcinoma and snail heterogeneity, Abcam Snai2 antibody (Abcam, ab180714) was used in immunohistochemistry - paraffin section on human samples at 1:75 (fig 2). BMC Cancer (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:100; fig 3
In order to elucidate the favor of Smad-independent TGF-beta signaling that drives EMT in pancreatic ductal adenocarcinoma due to TAp73 loss, Abcam Snai2 antibody (Abcam, ab-180714) was used in western blot on mouse samples at 1:100 (fig 3). Cell Death Differ (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:2000; fig 5
Abcam Snai2 antibody (abcam, ab27568) was used in western blot on human samples at 1:2000 (fig 5). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; 1:125; fig 2
Abcam Snai2 antibody (abcam, ab 27568) was used in immunocytochemistry on human samples at 1:125 (fig 2). Cytotechnology (2016) ncbi
domestic rabbit polyclonal
Abcam Snai2 antibody (Abcam, ab27568) was used . Biomed Res Int (2014) ncbi
Santa Cruz Biotechnology
mouse monoclonal (A-7)
  • western blot; human; 1:200; loading ...; fig 5a
Santa Cruz Biotechnology Snai2 antibody (Santa Cruz Biotechnology, sc-166476) was used in western blot on human samples at 1:200 (fig 5a). Cancers (Basel) (2021) ncbi
mouse monoclonal (A-7)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig 5
Santa Cruz Biotechnology Snai2 antibody (Santa Cruz, sc-166476) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 5). Int J Mol Sci (2021) ncbi
mouse monoclonal (A-7)
  • western blot; mouse; loading ...; fig 4a
Santa Cruz Biotechnology Snai2 antibody (Santa Cruz, A-7) was used in western blot on mouse samples (fig 4a). Oncogene (2018) ncbi
mouse monoclonal (C-7)
  • western blot; human; 1:1000; loading ...; fig 3c
Santa Cruz Biotechnology Snai2 antibody (Santa Cruz, sc-166902) was used in western blot on human samples at 1:1000 (fig 3c). Mol Med Rep (2017) ncbi
mouse monoclonal
  • western blot; human; 1:400; loading ...; fig 4d
In order to find that the 'steady step' level of engulfed extracellular miRNA and its subsequent activity is dependent on the presence of a donor cell and XRN1 exonuclease, Santa Cruz Biotechnology Snai2 antibody (Santa Cruz, A-7) was used in western blot on human samples at 1:400 (fig 4d). Nucleic Acids Res (2017) ncbi
mouse monoclonal (A-7)
  • western blot; human; 1:400; loading ...; fig 4d
In order to find that the 'steady step' level of engulfed extracellular miRNA and its subsequent activity is dependent on the presence of a donor cell and XRN1 exonuclease, Santa Cruz Biotechnology Snai2 antibody (Santa Cruz, A-7) was used in western blot on human samples at 1:400 (fig 4d). Nucleic Acids Res (2017) ncbi
mouse monoclonal (A-7)
  • western blot; human; 1:200; loading ...; fig 5c
Santa Cruz Biotechnology Snai2 antibody (SantaCruz, sc-166476) was used in western blot on human samples at 1:200 (fig 5c). Oncotarget (2016) ncbi
mouse monoclonal (A-7)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig 2
Santa Cruz Biotechnology Snai2 antibody (Santa Cruz, 166476) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 2). Oncotarget (2015) ncbi
mouse monoclonal (A-7)
  • immunohistochemistry - paraffin section; human; 1:100; fig 2
Santa Cruz Biotechnology Snai2 antibody (Santa Cruz, sc-166476) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2). BMC Cancer (2015) ncbi
mouse monoclonal (A-7)
  • western blot; human; 1:500; fig 6c
Santa Cruz Biotechnology Snai2 antibody (santa cruz, sc-166476) was used in western blot on human samples at 1:500 (fig 6c). Oncol Rep (2015) ncbi
mouse monoclonal
  • western blot; human; 1:1000; loading ...; fig 2a
Santa Cruz Biotechnology Snai2 antibody (Santa Cruz, clone A-7) was used in western blot on human samples at 1:1000 (fig 2a). Osteoarthritis Cartilage (2015) ncbi
mouse monoclonal (A-7)
  • western blot; human; 1:500; loading ...; fig 2d
Santa Cruz Biotechnology Snai2 antibody (Santa Cruz, sc-166476) was used in western blot on human samples at 1:500 (fig 2d). Cancer Lett (2015) ncbi
mouse monoclonal (A-7)
  • western blot; human; 1:500
Santa Cruz Biotechnology Snai2 antibody (Santa Cruz Biotechnology, sc-166476) was used in western blot on human samples at 1:500. Cell Death Dis (2014) ncbi
Novus Biologicals
mouse monoclonal (OTI1A6)
  • immunohistochemistry - paraffin section; human; 1:300; loading ...; fig 3k, 3l
Novus Biologicals Snai2 antibody (Novus Biologicals, OTI1A6) was used in immunohistochemistry - paraffin section on human samples at 1:300 (fig 3k, 3l). Cancers (Basel) (2021) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (C19G7)
  • western blot; human; 1:1000; loading ...; fig 4a, 4d
Cell Signaling Technology Snai2 antibody (CST, 9585S) was used in western blot on human samples at 1:1000 (fig 4a, 4d). Cell Death Discov (2022) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; loading ...; fig 4b
Cell Signaling Technology Snai2 antibody (CST, 9585) was used in western blot on human samples (fig 4b). Cell Death Discov (2022) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; mouse; loading ...; fig 6g
Cell Signaling Technology Snai2 antibody (CST, 9585) was used in western blot on mouse samples (fig 6g). Front Oncol (2022) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; 1:100; fig 3e
Cell Signaling Technology Snai2 antibody (Cell signaling, C19G7) was used in western blot on human samples at 1:100 (fig 3e). Am J Cancer Res (2022) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; 1:1000; loading ...; fig s9c
Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in western blot on human samples at 1:1000 (fig s9c). Proc Natl Acad Sci U S A (2022) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; loading ...; fig 5a
Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in western blot on human samples (fig 5a). Transl Oncol (2022) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; fig 8e
Cell Signaling Technology Snai2 antibody (CST, 9585) was used in western blot on human samples (fig 8e). Cell Death Dis (2021) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; 1:1000; loading ...; fig 5a, 5c
Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in western blot on human samples at 1:1000 (fig 5a, 5c). Mol Med Rep (2021) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; loading ...; fig 6a, 6b
Cell Signaling Technology Snai2 antibody (Cell Signaling Technology, 9585S) was used in western blot on human samples (fig 6a, 6b). Clin Transl Med (2021) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; 1:1000; loading ...; fig 4c
Cell Signaling Technology Snai2 antibody (CST, 9585) was used in western blot on human samples at 1:1000 (fig 4c). Cancer Sci (2021) ncbi
domestic rabbit monoclonal (C19G7)
  • immunohistochemistry - paraffin section; mouse; 1:400; loading ...; fig 5e
  • immunocytochemistry; mouse; 1:400; loading ...; fig s6d
  • western blot; mouse; 1:1000; loading ...; fig 6i
Cell Signaling Technology Snai2 antibody (CST, 9585) was used in immunohistochemistry - paraffin section on mouse samples at 1:400 (fig 5e), in immunocytochemistry on mouse samples at 1:400 (fig s6d) and in western blot on mouse samples at 1:1000 (fig 6i). Front Cell Dev Biol (2021) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; 1:1000; loading ...; fig 4g
Cell Signaling Technology Snai2 antibody (CST, 9585) was used in western blot on human samples at 1:1000 (fig 4g). Front Oncol (2021) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; 1:1000; loading ...; fig 4c, 4d
Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in western blot on human samples at 1:1000 (fig 4c, 4d). Acta Pharm Sin B (2021) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; loading ...; fig 6d
Cell Signaling Technology Snai2 antibody (Cell Signaling Technology, 9585) was used in western blot on human samples (fig 6d). J Exp Clin Cancer Res (2021) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; 1:1000; loading ...; fig 2b
Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in western blot on human samples at 1:1000 (fig 2b). Biology (Basel) (2021) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; loading ...; fig 3b
Cell Signaling Technology Snai2 antibody (Cell Signaling Technology, 9585) was used in western blot on human samples (fig 3b). Biomol Ther (Seoul) (2021) ncbi
domestic rabbit monoclonal (C19G7)
  • immunohistochemistry; mouse; loading ...; fig s3b
Cell Signaling Technology Snai2 antibody (Cell Signaling Technology, 9585) was used in immunohistochemistry on mouse samples (fig s3b). Cell Rep (2021) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; 1:1000; loading ...; fig 5
Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585S) was used in western blot on human samples at 1:1000 (fig 5). Exp Hematol Oncol (2021) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; loading ...; fig 3c
Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in western blot on human samples (fig 3c). J Cell Mol Med (2021) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; 1:500; loading ...; fig 3h
Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in western blot on human samples at 1:500 (fig 3h). Commun Biol (2021) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; 1:1000; loading ...; fig s5d
Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in western blot on human samples at 1:1000 (fig s5d). J Exp Clin Cancer Res (2021) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; 1:1000; loading ...
Cell Signaling Technology Snai2 antibody (Cell Signaling Technology, 9585 s) was used in western blot on human samples at 1:1000. Cell Biosci (2020) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; fig 5b
Cell Signaling Technology Snai2 antibody (Cell Signaling Technology, C19G7) was used in western blot on human samples (fig 5b). Sci Adv (2020) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; 1:1000; loading ...; fig 6a
Cell Signaling Technology Snai2 antibody (Cell Signaling Technology, 9585) was used in western blot on human samples at 1:1000 (fig 6a). Cell Prolif (2020) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; 1:1000; loading ...; fig 5
Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in western blot on human samples at 1:1000 (fig 5). Oncol Lett (2020) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; 1:1000; loading ...; fig 5b,
Cell Signaling Technology Snai2 antibody (Cell Signaling Technology, Danvers, MA;, 9585) was used in western blot on human samples at 1:1000 (fig 5b, ). Integr Cancer Ther (2020) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; loading ...; fig 5e
Cell Signaling Technology Snai2 antibody (CST, 9585) was used in western blot on human samples (fig 5e). Sci Adv (2020) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; fig 4e
Cell Signaling Technology Snai2 antibody (Cell signaling, 9585) was used in western blot on human samples (fig 4e). Oncogenesis (2020) ncbi
domestic rabbit monoclonal (C19G7)
  • immunohistochemistry - paraffin section; mouse; 1:300; loading ...; fig 3e
  • western blot; mouse; 1:1000; loading ...; fig 3h
Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in immunohistochemistry - paraffin section on mouse samples at 1:300 (fig 3e) and in western blot on mouse samples at 1:1000 (fig 3h). Cancer Cell (2020) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; 1:1000; loading ...; fig 2k
Cell Signaling Technology Snai2 antibody (Cell Signaling, C19G7) was used in western blot on human samples at 1:1000 (fig 2k). Front Oncol (2019) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; loading ...; fig 3c
Cell Signaling Technology Snai2 antibody (CST, 9585) was used in western blot on human samples (fig 3c). Cell Death Dis (2020) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; fig 2e
Cell Signaling Technology Snai2 antibody (Cell signaling, 9585S) was used in western blot on human samples (fig 2e). Sci Rep (2019) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; loading ...; fig 5a
Cell Signaling Technology Snai2 antibody (Cell Signaling Technology, 9585) was used in western blot on human samples (fig 5a). Oncogene (2020) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; 1:500; loading ...; fig 3f
Cell Signaling Technology Snai2 antibody (CST, 9585) was used in western blot on human samples at 1:500 (fig 3f). Med Sci Monit (2019) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; loading ...; fig 2a
Cell Signaling Technology Snai2 antibody (CST, 9585) was used in western blot on human samples (fig 2a). Cell Commun Signal (2019) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; mouse; fig 4a
Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in western blot on mouse samples (fig 4a). Cell Rep (2019) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; loading ...; fig s11b
Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in western blot on human samples (fig s11b). Theranostics (2019) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; 1:500; loading ...; fig s2a
Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in western blot on human samples at 1:500 (fig s2a). Sci Adv (2019) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; rat; 1:250; loading ...; fig s3b
Cell Signaling Technology Snai2 antibody (Cell Signaling Technology, C19G7) was used in western blot on rat samples at 1:250 (fig s3b). J Cell Sci (2019) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; loading ...; fig 5a
Cell Signaling Technology Snai2 antibody (Cell Signaling Technology, 9585) was used in western blot on human samples (fig 5a). Exp Cell Res (2019) ncbi
domestic rabbit monoclonal (C19G7)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s4c
Cell Signaling Technology Snai2 antibody (Cell Signaling Technology, 95855) was used in immunohistochemistry - paraffin section on mouse samples (fig s4c). Cell (2019) ncbi
domestic rabbit monoclonal (C19G7)
  • immunohistochemistry - frozen section; mouse; 1:50; loading ...; fig s3d
Cell Signaling Technology Snai2 antibody (Cell signaling, C1967) was used in immunohistochemistry - frozen section on mouse samples at 1:50 (fig s3d). Science (2018) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; loading ...; fig 3b
Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in western blot on human samples (fig 3b). J Cell Mol Med (2018) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; 1:1000; fig s6i
Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in western blot on human samples at 1:1000 (fig s6i). Nat Commun (2017) ncbi
domestic rabbit monoclonal (C19G7)
  • ChIP-Seq; human; loading ...; fig s3a
  • western blot; human; 1:300; loading ...; fig 4e
Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in ChIP-Seq on human samples (fig s3a) and in western blot on human samples at 1:300 (fig 4e). Cell Rep (2017) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; 1:1000; loading ...; fig 7j
Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in western blot on human samples at 1:1000 (fig 7j). J Clin Invest (2017) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; loading ...; fig 4b
Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in western blot on human samples (fig 4b). Nat Genet (2017) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; 1:1000; loading ...; fig 3a
Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in western blot on human samples at 1:1000 (fig 3a). Oncotarget (2017) ncbi
domestic rabbit monoclonal (C19G7)
  • immunocytochemistry; human; loading ...; fig 4c
  • western blot; human; loading ...; fig 4a
In order to investigate Rac1 activity and inhibition in gastric adenocarcinoma cells and mouse xenograft models for epithelial-to-mesenchymal transition and cancer stem-like cell phenotypes, Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in immunocytochemistry on human samples (fig 4c) and in western blot on human samples (fig 4a). Mol Cancer Res (2017) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; 1:500; loading ...; fig 4C
Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585P) was used in western blot on human samples at 1:500 (fig 4C). Oncol Lett (2017) ncbi
domestic rabbit monoclonal (C19G7)
  • immunocytochemistry; mouse; 1:200; loading ...; fig 1a
In order to investigate the gene expression dynamics of early mouse embryonic stem cell differentiation, Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in immunocytochemistry on mouse samples at 1:200 (fig 1a). elife (2017) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; 1:1000; loading ...; fig 6d
Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in western blot on human samples at 1:1000 (fig 6d). Int J Mol Med (2017) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; 1:1000; loading ...; fig s1e
Cell Signaling Technology Snai2 antibody (Cell Signalling, 9585S) was used in western blot on human samples at 1:1000 (fig s1e). Nat Commun (2017) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; loading ...; fig s2
In order to evaluate the physical and functional interaction of elongation factor, RNA polymerase II, 2 with retinoblastoma in prostate cancer, Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in western blot on human samples (fig s2). Neoplasia (2017) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; loading ...
Cell Signaling Technology Snai2 antibody (Cell Signaling Technology, 9585) was used in western blot on human samples . Neoplasia (2017) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; loading ...; fig 3d
Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in western blot on human samples (fig 3d). Cell Rep (2017) ncbi
domestic rabbit monoclonal (C19G7)
  • immunohistochemistry; chicken; 1:100; loading ...; fig 4g
In order to study cranial neural crest epithelial-to-mesenchymal transitions, Cell Signaling Technology Snai2 antibody (Cell Signaling, C19G7) was used in immunohistochemistry on chicken samples at 1:100 (fig 4g). J Cell Biol (2016) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; fig 1a
Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in western blot on human samples (fig 1a). PLoS ONE (2016) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; loading ...; fig 2h
Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in western blot on human samples (fig 2h). Oncotarget (2016) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; loading ...; fig 4a
In order to propose that loss of Llgl1 results in epidermal growth factor receptor mislocalization and leads to pre-neoplastic changes, Cell Signaling Technology Snai2 antibody (cell signalling, 9585) was used in western blot on human samples (fig 4a). Oncotarget (2016) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; 1:1000; loading ...; fig 3b
In order to report how PTEN alters breast cancer metastatic behavior, Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in western blot on human samples at 1:1000 (fig 3b). Anticancer Res (2016) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; 1:1000; loading ...; fig 3a
Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in western blot on human samples at 1:1000 (fig 3a). Drug Des Devel Ther (2016) ncbi
domestic rabbit monoclonal (C19G7)
  • immunocytochemistry; mouse; loading ...; fig 3b
In order to identify keratin-associated protein 5-5 as a driver of endothelial monolayer invasion, Cell Signaling Technology Snai2 antibody (Cell Signaling Technology, 9585) was used in immunocytochemistry on mouse samples (fig 3b). Oncogene (2017) ncbi
domestic rabbit monoclonal (C19G7)
  • immunohistochemistry; mouse; loading ...; fig 8j
Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in immunohistochemistry on mouse samples (fig 8j). Oncogene (2017) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; loading ...; fig 1b
Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in western blot on human samples (fig 1b). Oncotarget (2016) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; 1:1000; loading ...; fig 4a
Cell Signaling Technology Snai2 antibody (cell signalling, 9585) was used in western blot on human samples at 1:1000 (fig 4a). Oncotarget (2016) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; rat; 1:1000; fig 3
Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in western blot on rat samples at 1:1000 (fig 3). Front Pharmacol (2016) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; fig 2
Cell Signaling Technology Snai2 antibody (Cell signaling, 9585) was used in western blot on human samples (fig 2). Mol Biol Rep (2016) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; 1:1000; fig 6
In order to characterize attenuation of triple negative breast cancer cells metastatic potential by the vitamin D analog, MART-10, Cell Signaling Technology Snai2 antibody (Cell Signaling Technology, 9585) was used in western blot on human samples at 1:1000 (fig 6). Int J Mol Sci (2016) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; fig s3
Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in western blot on human samples (fig s3). Cell Death Dis (2016) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; 1:1000; fig 1
In order to analyze attenuation of transforming growth factor-beta signaling and metastatic activity of triple-negative breast cancer cells by Kaiso depletion, Cell Signaling Technology Snai2 antibody (Cell signaling, C19G7) was used in western blot on human samples at 1:1000 (fig 1). Oncogenesis (2016) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; fig 7
Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in western blot on human samples (fig 7). Oncotarget (2016) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; fig 6
In order to analyze repression of tumorigenesis and modulation of epithelial-to-mesenchymal transition in bladder carcinoma cells by prostate-derived ets factor, Cell Signaling Technology Snai2 antibody (Cell signaling, C19G7) was used in western blot on human samples (fig 6). Cancer Lett (2016) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; 1:1000; fig 4
Cell Signaling Technology Snai2 antibody (Cell Signaling Tech, 9585) was used in western blot on human samples at 1:1000 (fig 4). PLoS ONE (2016) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; 1:1000; fig 3
In order to study the interaction with YAP1 in aggressive cancer types by ZEB1 turning into a transcriptional activator, Cell Signaling Technology Snai2 antibody (Cell Signaling Technology, 9585) was used in western blot on human samples at 1:1000 (fig 3). Nat Commun (2016) ncbi
domestic rabbit monoclonal (C19G7)
  • chromatin immunoprecipitation; human; 1:500; fig 3
  • western blot; human; 1:500; fig 2
Cell Signaling Technology Snai2 antibody (Cell Signaling Technology, 9585) was used in chromatin immunoprecipitation on human samples at 1:500 (fig 3) and in western blot on human samples at 1:500 (fig 2). Nat Commun (2016) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; 1:1000; loading ...; fig 4h
Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in western blot on human samples at 1:1000 (fig 4h). Int J Oncol (2016) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; 1:500; fig 3
Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in western blot on human samples at 1:500 (fig 3). Nature (2015) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; loading ...; fig 3c
Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in western blot on human samples (fig 3c). Oncogene (2016) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; fig 6a
In order to demonstrate that LRIG1 functions as a growth suppressor in breast cancer cells, Cell Signaling Technology Snai2 antibody (Cell Signaling Technology, 9585) was used in western blot on human samples (fig 6a). Oncogene (2016) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; mouse; 1:1000; fig 1
In order to investigate how reprogramming of fibroblasts into cardiomyocytes requires suppression of pro-fibrotic signaling, Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585S) was used in western blot on mouse samples at 1:1000 (fig 1). Nat Commun (2015) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; 1:1000; fig 4
In order to examine the effects of vitamin D on anaplastic thyroid cancer, Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in western blot on human samples at 1:1000 (fig 4). Cancer Lett (2015) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; fig 7a
In order to analyze growth differentiation factor-15 as a p53- and demehtylation-upregulating gene that represses invasion, cell proliferation, and tumorigenesis in bladder carcinoma cells, Cell Signaling Technology Snai2 antibody (Cell Signaling Technology, C19G7) was used in western blot on human samples (fig 7a). Sci Rep (2015) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; fig 4
Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585S) was used in western blot on human samples (fig 4). J Biomed Sci (2015) ncbi
domestic rabbit monoclonal (C19G7)
  • immunohistochemistry - paraffin section; human; 1:30; fig 2
In order to characterize triple-negative breast cancer and the role of epithelial-mesenchymal transition markers, Cell Signaling Technology Snai2 antibody (Cell Signalling, 9585) was used in immunohistochemistry - paraffin section on human samples at 1:30 (fig 2). Breast Cancer Res Treat (2015) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; mouse; fig 1
Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in western blot on mouse samples (fig 1). Oncogene (2015) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; fig s7
Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in western blot on human samples (fig s7). Oncogene (2016) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; fig 6
Cell Signaling Technology Snai2 antibody (Cell Signaling Tech, 9585) was used in western blot on human samples (fig 6). PLoS ONE (2015) ncbi
domestic rabbit monoclonal (C19G7)
  • immunohistochemistry - paraffin section; mouse
  • western blot; mouse
In order to investigate the effect of miR-200c on claudin-low breast cancer, Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in immunohistochemistry - paraffin section on mouse samples and in western blot on mouse samples . Oncogene (2015) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; fig 3
In order to elucidate the tumor suppressor function of BTG3, Cell Signaling Technology Snai2 antibody (Cell Signaling Technologies, 9585) was used in western blot on human samples (fig 3). Cell Death Dis (2015) ncbi
domestic rabbit monoclonal (C19G7)
  • flow cytometry; human
Cell Signaling Technology Snai2 antibody (Cell Signaling Technology, 9585) was used in flow cytometry on human samples . Clin Cancer Res (2015) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; mouse
Cell Signaling Technology Snai2 antibody (Cell Signalling, 9585) was used in western blot on mouse samples . Stem Cells (2015) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; 1:3000; fig s3c
In order to assess the functionality of BRCA1 in the heterozygous state, Cell Signaling Technology Snai2 antibody (Cell Signaling,, C19G7) was used in western blot on human samples at 1:3000 (fig s3c). Nat Commun (2014) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human
In order to identify the role of obscurins during breast carcinogenesis, Cell Signaling Technology Snai2 antibody (Cell Signaling Technology, 9585) was used in western blot on human samples . Oncogene (2015) ncbi
domestic rabbit monoclonal (C19G7)
  • immunohistochemistry - paraffin section; human; 1:10
Cell Signaling Technology Snai2 antibody (Cell Signaling Technology, C19G7) was used in immunohistochemistry - paraffin section on human samples at 1:10. J Pathol (2015) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; 1:500
In order to determine the role and function of NDRG1 in oral squamous cell carcinoma, Cell Signaling Technology Snai2 antibody (Cell Signaling, C19G7) was used in western blot on human samples at 1:500. Cancer Lett (2014) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human
In order to study how phosphorylation alters COP1-binding sites of oncoproteins, Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in western blot on human samples . Cancer Cell (2014) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; 1:500
Cell Signaling Technology Snai2 antibody (Cell Signaling Technology, 9585) was used in western blot on human samples at 1:500. Urol Oncol (2014) ncbi
domestic rabbit monoclonal (C19G7)
  • immunohistochemistry - paraffin section; human; 1:200
Cell Signaling Technology Snai2 antibody (Cell Signaling Technologies, 9585) was used in immunohistochemistry - paraffin section on human samples at 1:200. J Histochem Cytochem (2014) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human
Cell Signaling Technology Snai2 antibody (Cell Signaling Technology, 9585) was used in western blot on human samples . PLoS ONE (2014) ncbi
domestic rabbit monoclonal (C19G7)
  • immunohistochemistry; human; 1:100
In order to discuss a clinical case of intracranial extension of adenoid cystic carcinoma, Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in immunohistochemistry on human samples at 1:100. BMC Res Notes (2014) ncbi
domestic rabbit monoclonal (C19G7)
  • immunocytochemistry; human
  • western blot; human
In order to evaluate the prognostic value of fascin in pancreatic cancer, Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in immunocytochemistry on human samples and in western blot on human samples . Gastroenterology (2014) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human
Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585p) was used in western blot on human samples . Cancer Res (2014) ncbi
domestic rabbit monoclonal (C19G7)
  • immunohistochemistry; human; 1:100
In order to characterize a rare case of gliosarcoma, Cell Signaling Technology Snai2 antibody (CST, 9585) was used in immunohistochemistry on human samples at 1:100. Clin Neuropathol (2013) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human; 1:1000
Cell Signaling Technology Snai2 antibody (Cell Signaling Technology, 9585) was used in western blot on human samples at 1:1000. Oncogene (2014) ncbi
domestic rabbit monoclonal (C19G7)
  • immunohistochemistry - frozen section; mouse
In order to study the role of endothelial-to-mesenchymal transition in the onset and progression of cerebral cavernous malformations, Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in immunohistochemistry - frozen section on mouse samples . Nature (2013) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human
In order to examine the relation of GATA3 and TGF beta in breast cancer cells, Cell Signaling Technology Snai2 antibody (Cell Signaling Technology, 9585) was used in western blot on human samples . PLoS ONE (2013) ncbi
domestic rabbit monoclonal (C19G7)
  • immunohistochemistry - paraffin section; human; 1:100
Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585) was used in immunohistochemistry - paraffin section on human samples at 1:100. PLoS ONE (2012) ncbi
domestic rabbit monoclonal (C19G7)
  • western blot; human
Cell Signaling Technology Snai2 antibody (Cell Signaling, 9585S) was used in western blot on human samples . J Biol Chem (2012) ncbi
Developmental Studies Hybridoma Bank
mouse monoclonal (M-Pax4-1F3A3)
  • immunocytochemistry; human; 1:25; loading ...; tbl 1
In order to describe a method to produce human embryonic stem cell-derived Beta-like cells, Developmental Studies Hybridoma Bank Snai2 antibody (Hybridoma Bank, M-Pax4-1F3A3) was used in immunocytochemistry on human samples at 1:25 (tbl 1). PLoS ONE (2016) ncbi
Articles Reviewed
  1. Mukherjee B, Tiwari A, Palo A, Pattnaik N, Samantara S, Dixit M. Reduced expression of FRG1 facilitates breast cancer progression via GM-CSF/MEK-ERK axis by abating FRG1 mediated transcriptional repression of GM-CSF. Cell Death Discov. 2022;8:442 pubmed publisher
  2. Wu T, Wang W, Shi G, Hao M, Wang Y, Yao M, et al. Targeting HIC1/TGF-β axis-shaped prostate cancer microenvironment restrains its progression. Cell Death Dis. 2022;13:624 pubmed publisher
  3. Yun E, Kim D, Hsieh J, Baek S. Stanniocalcin 2 drives malignant transformation of human glioblastoma cells by targeting SNAI2 and Matrix Metalloproteinases. Cell Death Discov. 2022;8:308 pubmed publisher
  4. Chi R, Yao C, Chen S, Liu Y, He Y, Zhang J, et al. Elevated BCAA Suppresses the Development and Metastasis of Breast Cancer. Front Oncol. 2022;12:887257 pubmed publisher
  5. Castillo P, Aisagbonhi O, Saenz C, ElShamy W. Novel insights linking BRCA1-IRIS role in mammary gland development to formation of aggressive PABCs: the case for longer breastfeeding. Am J Cancer Res. 2022;12:396-426 pubmed
  6. Wolpaw A, Grossmann L, Dessau J, Dong M, Aaron B, Brafford P, et al. Epigenetic state determines inflammatory sensing in neuroblastoma. Proc Natl Acad Sci U S A. 2022;119: pubmed publisher
  7. Yang J, Liao Q, Price M, Moriarity B, Wolf N, Felices M, et al. Chondroitin sulfate proteoglycan 4, a targetable oncoantigen that promotes ovarian cancer growth, invasion, cisplatin resistance and spheroid formation. Transl Oncol. 2022;16:101318 pubmed publisher
  8. Zhu H, Su Z, Ning J, Zhou L, Tan L, Sayed S, et al. Transmembrane protein 97 exhibits oncogenic properties via enhancing LRP6-mediated Wnt signaling in breast cancer. Cell Death Dis. 2021;12:912 pubmed publisher
  9. Chen R, Sheng C, Ma R, Zhang L, Yang L, Chen Y. PLAC1 is an independent predictor of poor survival, and promotes cell proliferation and invasion in cervical cancer. Mol Med Rep. 2021;24: pubmed publisher
  10. Shi Y, Hu Y, Wang Y, Ma X, Tang L, Tao M, et al. Blockade of Autophagy Prevents the Development and Progression of Peritoneal Fibrosis. Front Pharmacol. 2021;12:724141 pubmed publisher
  11. Wang C, Yang Z, Xu E, Shen X, Wang X, Li Z, et al. Apolipoprotein C-II induces EMT to promote gastric cancer peritoneal metastasis via PI3K/AKT/mTOR pathway. Clin Transl Med. 2021;11:e522 pubmed publisher
  12. Wang K, Liu S, Dou Z, Zhang S, Yang X. Loss of Krüppel-like factor 9 facilitates stemness in ovarian cancer ascites-derived multicellular spheroids via Notch1/slug signaling. Cancer Sci. 2021;112:4220-4233 pubmed publisher
  13. Shao C, Lou P, Liu R, Bi X, Li G, Yang X, et al. Hormone-Responsive BMP Signaling Expands Myoepithelial Cell Lineages and Prevents Alveolar Precocity in Mammary Gland. Front Cell Dev Biol. 2021;9:691050 pubmed publisher
  14. Yu D, Yang X, Lin J, Cao Z, Lu C, Yang Z, et al. Super-Enhancer Induced IL-20RA Promotes Proliferation/Metastasis and Immune Evasion in Colorectal Cancer. Front Oncol. 2021;11:724655 pubmed publisher
  15. Fan M, Zhang G, Chen W, Qi L, Xie M, Zhang Y, et al. Siglec-15 Promotes Tumor Progression in Osteosarcoma via DUSP1/MAPK Pathway. Front Oncol. 2021;11:710689 pubmed publisher
  16. Zou J, Zhu X, Xiang D, Zhang Y, Li J, Su Z, et al. LIX1-like protein promotes liver cancer progression via miR-21-3p-mediated inhibition of fructose-1,6-bisphosphatase. Acta Pharm Sin B. 2021;11:1578-1591 pubmed publisher
  17. Cheng X, Wang J, Liu C, Jiang T, Yang N, Liu D, et al. Zinc transporter SLC39A13/ZIP13 facilitates the metastasis of human ovarian cancer cells via activating Src/FAK signaling pathway. J Exp Clin Cancer Res. 2021;40:199 pubmed publisher
  18. Xu Z, Cheng C, Kong R, Liu Y, Wang S, Ma Y, et al. S100A8 and S100A9, both transcriptionally regulated by PU.1, promote epithelial-mesenchymal transformation (EMT) and invasive growth of dermal keratinocytes during scar formation post burn. Aging (Albany NY). 2021;13:15523-15537 pubmed publisher
  19. Urdiciain A, Erausquin E, Zelaya M, Zazpe I, Lanciego J, Melendez B, et al. Silencing of Histone Deacetylase 6 Decreases Cellular Malignancy and Contributes to Primary Cilium Restoration, Epithelial-to-Mesenchymal Transition Reversion, and Autophagy Inhibition in Glioblastoma Cell Lines. Biology (Basel). 2021;10: pubmed publisher
  20. Lin C, Tsai M, Chen Y, Liu W, Lin C, Hsu K, et al. Platelet-Derived Growth Factor Receptor-α Subunit Targeting Suppresses Metastasis in Advanced Thyroid Cancer In Vitro and In Vivo. Biomol Ther (Seoul). 2021;29:551-561 pubmed publisher
  21. Sbiera I, Kircher S, Altieri B, Fassnacht M, Kroiss M, Sbiera S. Epithelial and Mesenchymal Markers in Adrenocortical Tissues: How Mesenchymal Are Adrenocortical Tissues?. Cancers (Basel). 2021;13: pubmed publisher
  22. Loureiro J, Raimundo L, Calheiros J, Carvalho C, Barcherini V, Lima N, et al. Targeting p53 for Melanoma Treatment: Counteracting Tumour Proliferation, Dissemination and Therapeutic Resistance. Cancers (Basel). 2021;13: pubmed publisher
  23. Carstens J, Yang S, Correa de Sampaio P, Zheng X, Barua S, McAndrews K, et al. Stabilized epithelial phenotype of cancer cells in primary tumors leads to increased colonization of liver metastasis in pancreatic cancer. Cell Rep. 2021;35:108990 pubmed publisher
  24. Yang S, Zhang H, Yang H, Zhang J, Wang J, Luo T, et al. SEPHS1 promotes SMAD2/3/4 expression and hepatocellular carcinoma cells invasion. Exp Hematol Oncol. 2021;10:17 pubmed publisher
  25. Blasiak J, Koskela A, Pawlowska E, Liukkonen M, Ruuth J, Toropainen E, et al. Epithelial-Mesenchymal Transition and Senescence in the Retinal Pigment Epithelium of NFE2L2/PGC-1α Double Knock-Out Mice. Int J Mol Sci. 2021;22: pubmed publisher
  26. Ding L, Fang Y, Li Y, Hu Q, Ai M, Deng K, et al. AIMP3 inhibits cell growth and metastasis of lung adenocarcinoma through activating a miR-96-5p-AIMP3-p53 axis. J Cell Mol Med. 2021;25:3019-3030 pubmed publisher
  27. Burgess S, Gibbs H, Toomes C, Coletta P, Bell S. The Role of Csmd1 during Mammary Gland Development. Genes (Basel). 2021;12: pubmed publisher
  28. Hu X, Villodre E, Larson R, Rahal O, Wang X, Gong Y, et al. Decorin-mediated suppression of tumorigenesis, invasion, and metastasis in inflammatory breast cancer. Commun Biol. 2021;4:72 pubmed publisher
  29. Jiang Y, Han Q, Zhao H, Zhang J. Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis. J Exp Clin Cancer Res. 2021;40:13 pubmed publisher
  30. Jiang X, Xu Y, Ren H, Jiang J, Wudu M, Wang Q, et al. KLHL18 inhibits the proliferation, migration, and invasion of non-small cell lung cancer by inhibiting PI3K/PD-L1 axis activity. Cell Biosci. 2020;10:139 pubmed publisher
  31. Shi H, Tao T, Abraham B, Durbin A, Zimmerman M, Kadoch C, et al. ARID1A loss in neuroblastoma promotes the adrenergic-to-mesenchymal transition by regulating enhancer-mediated gene expression. Sci Adv. 2020;6:eaaz3440 pubmed publisher
  32. Huang W, Yu D, Wang M, Han Y, Lin J, Wei D, et al. ITGBL1 promotes cell migration and invasion through stimulating the TGF-β signalling pathway in hepatocellular carcinoma. Cell Prolif. 2020;53:e12836 pubmed publisher
  33. Liang W, Gao R, Yang M, Wang X, Cheng K, Shi X, et al. MARCKSL1 promotes the proliferation, migration and invasion of lung adenocarcinoma cells. Oncol Lett. 2020;19:2272-2280 pubmed publisher
  34. Chen Z, Zhang J, Xue H, Qian M, Guo X, Gao X, et al. Nitidine Chloride Is a Potential Alternative Therapy for Glioma Through Inducing Endoplasmic Reticulum Stress and Alleviating Epithelial-Mesenchymal Transition. Integr Cancer Ther. 2020;19:1534735419900927 pubmed publisher
  35. Tian S, Peng P, Li J, Deng H, Zhan N, Zeng Z, et al. SERPINH1 regulates EMT and gastric cancer metastasis via the Wnt/β-catenin signaling pathway. Aging (Albany NY). 2020;12:3574-3593 pubmed publisher
  36. Aldonza M, Ku J, Hong J, Kim D, Yu S, Lee M, et al. Prior acquired resistance to paclitaxel relays diverse EGFR-targeted therapy persistence mechanisms. Sci Adv. 2020;6:eaav7416 pubmed publisher
  37. Chandrasekaran B, Dahiya N, Tyagi A, Kolluru V, Saran U, Baby B, et al. Chronic exposure to cadmium induces a malignant transformation of benign prostate epithelial cells. Oncogenesis. 2020;9:23 pubmed publisher
  38. Gu Y, Zhu Z, Pei H, Xu D, Jiang Y, Zhang L, et al. Long non-coding RNA NNT-AS1 promotes cholangiocarcinoma cells proliferation and epithelial-to-mesenchymal transition through down-regulating miR-203. Aging (Albany NY). 2020;12:2333-2346 pubmed publisher
  39. Brill Karniely Y, Dror D, Duanis Assaf T, Goldstein Y, Schwob O, Millo T, et al. Triangular correlation (TrC) between cancer aggressiveness, cell uptake capability, and cell deformability. Sci Adv. 2020;6:eaax2861 pubmed publisher
  40. Cheung E, DeNicola G, Nixon C, Blyth K, Labuschagne C, Tuveson D, et al. Dynamic ROS Control by TIGAR Regulates the Initiation and Progression of Pancreatic Cancer. Cancer Cell. 2020;37:168-182.e4 pubmed publisher
  41. Cai H, Li J, Zhang Y, Liao Y, Zhu Y, Wang C, et al. LDHA Promotes Oral Squamous Cell Carcinoma Progression Through Facilitating Glycolysis and Epithelial-Mesenchymal Transition. Front Oncol. 2019;9:1446 pubmed publisher
  42. Liu X, Ma F, Liu C, Zhu K, Li W, Xu Y, et al. UBE2O promotes the proliferation, EMT and stemness properties of breast cancer cells through the UBE2O/AMPKα2/mTORC1-MYC positive feedback loop. Cell Death Dis. 2020;11:10 pubmed publisher
  43. Hu Y, Ma Y, Liu J, Cai Y, Zhang M, Fang X. LINC01128 expedites cervical cancer progression by regulating miR-383-5p/SFN axis. BMC Cancer. 2019;19:1157 pubmed publisher
  44. Zhou S, da Silva S, Siegel P, Philip A. CD109 acts as a gatekeeper of the epithelial trait by suppressing epithelial to mesenchymal transition in squamous cell carcinoma cells in vitro. Sci Rep. 2019;9:16317 pubmed publisher
  45. Chen X, Xiong X, Cui D, Yang F, Wei D, Li H, et al. DEPTOR is an in vivo tumor suppressor that inhibits prostate tumorigenesis via the inactivation of mTORC1/2 signals. Oncogene. 2020;39:1557-1571 pubmed publisher
  46. Jiao X, Ye J, Wang X, Yin X, Zhang G, Cheng X. KIAA1199, a Target of MicoRNA-486-5p, Promotes Papillary Thyroid Cancer Invasion by Influencing Epithelial-Mesenchymal Transition (EMT). Med Sci Monit. 2019;25:6788-6796 pubmed publisher
  47. Ruffenach G, Umar S, Vaillancourt M, Hong J, Cao N, Sarji S, et al. Histological hallmarks and role of Slug/PIP axis in pulmonary hypertension secondary to pulmonary fibrosis. EMBO Mol Med. 2019;11:e10061 pubmed publisher
  48. Jiang S, Zhang M, Zhang Y, Zhou W, Zhu T, Ruan Q, et al. WNT5B governs the phenotype of basal-like breast cancer by activating WNT signaling. Cell Commun Signal. 2019;17:109 pubmed publisher
  49. Chang Z. Downregulation of SOX2 may be targeted by miR-590-5p and inhibits epithelial-to-mesenchymal transition in non-small-cell lung cancer. Exp Ther Med. 2019;18:1189-1195 pubmed publisher
  50. Gross K, Zhou W, Breindel J, Ouyang J, Jin D, Sokol E, et al. Loss of Slug Compromises DNA Damage Repair and Accelerates Stem Cell Aging in Mammary Epithelium. Cell Rep. 2019;28:394-407.e6 pubmed publisher
  51. Du F, Qiao C, Li X, Chen Z, Liu H, Wu S, et al. Forkhead box K2 promotes human colorectal cancer metastasis by upregulating ZEB1 and EGFR. Theranostics. 2019;9:3879-3902 pubmed publisher
  52. Sonego M, Pellarin I, Costa A, Vinciguerra G, Coan M, Kraut A, et al. USP1 links platinum resistance to cancer cell dissemination by regulating Snail stability. Sci Adv. 2019;5:eaav3235 pubmed publisher
  53. Jalal S, Shi S, Acharya V, Huang R, Viasnoff V, Bershadsky A, et al. Actin cytoskeleton self-organization in single epithelial cells and fibroblasts under isotropic confinement. J Cell Sci. 2019;132: pubmed publisher
  54. Guan H, Li N, Wang X, Shan X, Li Z, Lin Z. Role of Paip1 on angiogenesis and invasion in pancreatic cancer. Exp Cell Res. 2019;376:198-209 pubmed publisher
  55. Sharon N, Chawla R, Mueller J, Vanderhooft J, Whitehorn L, Rosenthal B, et al. A Peninsular Structure Coordinates Asynchronous Differentiation with Morphogenesis to Generate Pancreatic Islets. Cell. 2019;176:790-804.e13 pubmed publisher
  56. Pommier A, Anaparthy N, Memos N, Kelley Z, Gouronnec A, Yan R, et al. Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic cancer metastases. Science. 2018;360: pubmed publisher
  57. Vl kov K, Vachtenheim J, R da J, Hor k P, Ondru ov L. Inducibly decreased MITF levels do not affect proliferation and phenotype switching but reduce differentiation of melanoma cells. J Cell Mol Med. 2018;22:2240-2251 pubmed publisher
  58. Palesch D, Bosinger S, Tharp G, Vanderford T, Paiardini M, Chahroudi A, et al. Sooty mangabey genome sequence provides insight into AIDS resistance in a natural SIV host. Nature. 2018;553:77-81 pubmed publisher
  59. Wang J, Ye Q, Cao Y, Guo Y, Huang X, Mi W, et al. Snail determines the therapeutic response to mTOR kinase inhibitors by transcriptional repression of 4E-BP1. Nat Commun. 2017;8:2207 pubmed publisher
  60. Noutsou M, Li J, Ling J, Jones J, Wang Y, Chen Y, et al. The Cohesin Complex Is Necessary for Epidermal Progenitor Cell Function through Maintenance of Self-Renewal Genes. Cell Rep. 2017;20:3005-3013 pubmed publisher
  61. Comiskey D, Jacob A, Sanford B, Montes M, Goodwin A, Steiner H, et al. A novel mouse model of rhabdomyosarcoma underscores the dichotomy of MDM2-ALT1 function in vivo. Oncogene. 2018;37:95-106 pubmed publisher
  62. Caino M, Seo J, Wang Y, Rivadeneira D, Gabrilovich D, Kim E, et al. Syntaphilin controls a mitochondrial rheostat for proliferation-motility decisions in cancer. J Clin Invest. 2017;127:3755-3769 pubmed publisher
  63. Saxon J, Baer D, Barton J, Hawkins T, Wu B, Trusk T, et al. BMP2 expression in the endocardial lineage is required for AV endocardial cushion maturation and remodeling. Dev Biol. 2017;430:113-128 pubmed publisher
  64. van Groningen T, Koster J, Valentijn L, Zwijnenburg D, Akogul N, Hasselt N, et al. Neuroblastoma is composed of two super-enhancer-associated differentiation states. Nat Genet. 2017;49:1261-1266 pubmed publisher
  65. Lu J, Yang Y, Guo G, Liu Y, Zhang Z, Dong S, et al. IKBKE regulates cell proliferation and epithelial-mesenchymal transition of human malignant glioma via the Hippo pathway. Oncotarget. 2017;8:49502-49514 pubmed publisher
  66. Yoon C, Cho S, Chang K, Park D, Ryeom S, Yoon S. Role of Rac1 Pathway in Epithelial-to-Mesenchymal Transition and Cancer Stem-like Cell Phenotypes in Gastric Adenocarcinoma. Mol Cancer Res. 2017;15:1106-1116 pubmed publisher
  67. Hu X, Zhang Z, Liang Z, Xie D, Zhang T, Yu D, et al. Downregulation of feline sarcoma-related protein inhibits cell migration, invasion and epithelial-mesenchymal transition via the ERK/AP-1 pathway in bladder urothelial cell carcinoma. Oncol Lett. 2017;13:686-694 pubmed publisher
  68. Shen C, Kuo Y, Chen C, Chen M, Cheng Y. MMP1 expression is activated by Slug and enhances multi-drug resistance (MDR) in breast cancer. PLoS ONE. 2017;12:e0174487 pubmed publisher
  69. Jang S, Choubey S, Furchtgott L, Zou L, Doyle A, Menon V, et al. Dynamics of embryonic stem cell differentiation inferred from single-cell transcriptomics show a series of transitions through discrete cell states. elife. 2017;6: pubmed publisher
  70. Li X, Liu W, Chen X, Wang Y, Shi D, Zhang H, et al. Overexpression of TMPRSS4 promotes tumor proliferation and aggressiveness in breast cancer. Int J Mol Med. 2017;39:927-935 pubmed publisher
  71. Chen S, Wang Y, Zhang W, Dong M, Zhang J. Sclareolide enhances gemcitabine?induced cell death through mediating the NICD and Gli1 pathways in gemcitabine?resistant human pancreatic cancer. Mol Med Rep. 2017;15:1461-1470 pubmed publisher
  72. Zhang L, Liu H, Mu X, Cui J, Peng Z. Dysregulation of Fra1 expression by Wnt/β-catenin signalling promotes glioma aggressiveness through epithelial-mesenchymal transition. Biosci Rep. 2017;37: pubmed publisher
  73. Kim N, Cha Y, Lee J, Lee S, Yang J, Yun J, et al. Snail reprograms glucose metabolism by repressing phosphofructokinase PFKP allowing cancer cell survival under metabolic stress. Nat Commun. 2017;8:14374 pubmed publisher
  74. Qiu X, Pascal L, Song Q, Zang Y, Ai J, O Malley K, et al. Physical and Functional Interactions between ELL2 and RB in the Suppression of Prostate Cancer Cell Proliferation, Migration, and Invasion. Neoplasia. 2017;19:207-215 pubmed publisher
  75. Zhai S, Liu C, Zhang L, Zhu J, Guo J, Zhang J, et al. PLCE1 Promotes Esophageal Cancer Cell Progression by Maintaining the Transcriptional Activity of Snail. Neoplasia. 2017;19:154-164 pubmed publisher
  76. Gonzalez M, Martin E, Anwar T, Arellano Garcia C, Medhora N, Lama A, et al. Mesenchymal Stem Cell-Induced DDR2 Mediates Stromal-Breast Cancer Interactions and Metastasis Growth. Cell Rep. 2017;18:1215-1228 pubmed publisher
  77. Fang S, Yu L, Mei H, Yang J, Gao T, Cheng A, et al. Cisplatin promotes mesenchymal-like characteristics in osteosarcoma through Snail. Oncol Lett. 2016;12:5007-5014 pubmed publisher
  78. Zangari J, Ilie M, Rouaud F, Signetti L, Ohanna M, Didier R, et al. Rapid decay of engulfed extracellular miRNA by XRN1 exonuclease promotes transient epithelial-mesenchymal transition. Nucleic Acids Res. 2017;45:4131-4141 pubmed publisher
  79. Schiffmacher A, Xie V, Taneyhill L. Cadherin-6B proteolysis promotes the neural crest cell epithelial-to-mesenchymal transition through transcriptional regulation. J Cell Biol. 2016;215:735-747 pubmed
  80. Zhao X, Li L, Wang X, Fu R, Lv Y, Jin W, et al. Inhibition of Snail Family Transcriptional Repressor 2 (SNAI2) Enhances Multidrug Resistance of Hepatocellular Carcinoma Cells. PLoS ONE. 2016;11:e0164752 pubmed publisher
  81. Massumi M, Pourasgari F, Nalla A, Batchuluun B, Nagy K, Neely E, et al. An Abbreviated Protocol for In Vitro Generation of Functional Human Embryonic Stem Cell-Derived Beta-Like Cells. PLoS ONE. 2016;11:e0164457 pubmed publisher
  82. Karthikeyan S, Lantvit D, Chae D, Burdette J. Cadherin-6 type 2, K-cadherin (CDH6) is regulated by mutant p53 in the fallopian tube but is not expressed in the ovarian surface. Oncotarget. 2016;7:69871-69882 pubmed publisher
  83. Matkar P, Singh K, Rudenko D, Kim Y, Kuliszewski M, Prud homme G, et al. Novel regulatory role of neuropilin-1 in endothelial-to-mesenchymal transition and fibrosis in pancreatic ductal adenocarcinoma. Oncotarget. 2016;7:69489-69506 pubmed publisher
  84. Greenwood E, Maisel S, Ebertz D, Russ A, Pandey R, SCHROEDER J. Llgl1 prevents metaplastic survival driven by epidermal growth factor dependent migration. Oncotarget. 2016;7:60776-60792 pubmed publisher
  85. Li C, Li Q, Cai Y, He Y, Lan X, Wang W, et al. Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial-mesenchymal transition-induced angiogenesis. Cancer Gene Ther. 2016;23:295-302 pubmed publisher
  86. Chiang K, Hsu S, Lin S, Yeh C, Pang J, Wang S, et al. PTEN Insufficiency Increases Breast Cancer Cell Metastasis In Vitro and In Vivo in a Xenograft Zebrafish Model. Anticancer Res. 2016;36:3997-4005 pubmed
  87. Wei M, He W, Lu X, Ni L, Yang Y, Chen L, et al. JiaWeiDangGui Decoction Ameliorates Proteinuria and Kidney Injury in Adriamycin-Induced Rat by Blockade of TGF-?/Smad Signaling. Evid Based Complement Alternat Med. 2016;2016:5031890 pubmed publisher
  88. Yang S, Tsai C, Pan Y, Yeh C, Pang J, Takano M, et al. MART-10, a newly synthesized vitamin D analog, represses metastatic potential of head and neck squamous carcinoma cells. Drug Des Devel Ther. 2016;10:1995-2002 pubmed publisher
  89. Berens E, Sharif G, Schmidt M, Yan G, Shuptrine C, Weiner L, et al. Keratin-associated protein 5-5 controls cytoskeletal function and cancer cell vascular invasion. Oncogene. 2017;36:593-605 pubmed publisher
  90. Zhang Q, Liu S, Parajuli K, Zhang W, Zhang K, Mo Z, et al. Interleukin-17 promotes prostate cancer via MMP7-induced epithelial-to-mesenchymal transition. Oncogene. 2017;36:687-699 pubmed publisher
  91. Shriver M, Marimuthu S, Paul C, Geist J, Seale T, Konstantopoulos K, et al. Giant obscurins regulate the PI3K cascade in breast epithelial cells via direct binding to the PI3K/p85 regulatory subunit. Oncotarget. 2016;7:45414-45428 pubmed publisher
  92. Tisza M, Zhao W, Fuentes J, Prijic S, Chen X, Levental I, et al. Motility and stem cell properties induced by the epithelial-mesenchymal transition require destabilization of lipid rafts. Oncotarget. 2016;7:51553-51568 pubmed publisher
  93. Chuang H, Su H, Li C, Lin S, Yen S, Huang M, et al. The Role of Butylidenephthalide in Targeting the Microenvironment Which Contributes to Liver Fibrosis Amelioration. Front Pharmacol. 2016;7:112 pubmed publisher
  94. Lin S, Wang B, Lin C, Chien P, Wu Y, Ko J, et al. Chidamide alleviates TGF-?-induced epithelial-mesenchymal transition in lung cancer cell lines. Mol Biol Rep. 2016;43:687-95 pubmed publisher
  95. Ding H, Xu Y, Gao D, Wang L. Glioma-associated oncogene homolog 1 promotes epithelial-mesenchymal transition in human renal tubular epithelial cell. Am J Transl Res. 2016;8:662-9 pubmed
  96. Chiang K, Yeh T, Chen S, Pang J, Yeh C, Hsu J, et al. The Vitamin D Analog, MART-10, Attenuates Triple Negative Breast Cancer Cells Metastatic Potential. Int J Mol Sci. 2016;17: pubmed publisher
  97. Zhuang L, Yang Y, Ma X, Han B, Wang Z, Zhao Q, et al. MicroRNA-92b promotes hepatocellular carcinoma progression by targeting Smad7 and is mediated by long non-coding RNA XIST. Cell Death Dis. 2016;7:e2203 pubmed publisher
  98. Liu S, Zhou F, Shen Y, Zhang Y, Yin H, Zeng Y, et al. Fluid shear stress induces epithelial-mesenchymal transition (EMT) in Hep-2 cells. Oncotarget. 2016;7:32876-92 pubmed publisher
  99. Bassey Archibong B, Kwiecien J, Milosavljevic S, Hallett R, Rayner L, Erb M, et al. Kaiso depletion attenuates transforming growth factor-? signaling and metastatic activity of triple-negative breast cancer cells. Oncogenesis. 2016;5:e208 pubmed publisher
  100. Ananthula S, Sinha A, El Gassim M, Batth S, Marshall G, Gardner L, et al. Geminin overexpression-dependent recruitment and crosstalk with mesenchymal stem cells enhance aggressiveness in triple negative breast cancers. Oncotarget. 2016;7:20869-89 pubmed publisher
  101. Tsui K, Lin Y, Chung L, Chuang S, Feng T, Chiang K, et al. Prostate-derived ets factor represses tumorigenesis and modulates epithelial-to-mesenchymal transition in bladder carcinoma cells. Cancer Lett. 2016;375:142-151 pubmed publisher
  102. Zaldumbide L, Erramuzpe A, Guarch R, Pulido R, Cortés J, López J. Snail heterogeneity in clear cell renal cell carcinoma. BMC Cancer. 2016;16:194 pubmed publisher
  103. Thakur A, Nigri J, Lac S, Leca J, Bressy C, Berthezene P, et al. TAp73 loss favors Smad-independent TGF-β signaling that drives EMT in pancreatic ductal adenocarcinoma. Cell Death Differ. 2016;23:1358-70 pubmed publisher
  104. Chang T, Chen C, Wu Y, Liu J, Kuo Y, Lee K, et al. Inflammation Promotes Expression of Stemness-Related Properties in HBV-Related Hepatocellular Carcinoma. PLoS ONE. 2016;11:e0149897 pubmed publisher
  105. Lehmann W, Mossmann D, Kleemann J, Mock K, Meisinger C, Brummer T, et al. ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types. Nat Commun. 2016;7:10498 pubmed publisher
  106. Weyemi U, Redon C, Choudhuri R, Aziz T, Maeda D, Boufraqech M, et al. The histone variant H2A.X is a regulator of the epithelial-mesenchymal transition. Nat Commun. 2016;7:10711 pubmed publisher
  107. Gao Y, Zhao Y, Zhang J, Lu Y, Liu X, Geng P, et al. The dual function of PRMT1 in modulating epithelial-mesenchymal transition and cellular senescence in breast cancer cells through regulation of ZEB1. Sci Rep. 2016;6:19874 pubmed publisher
  108. Gho C, Schomann T, de Groot S, Frijns J, Rivolta M, Neumann M, et al. Isolation, expansion and neural differentiation of stem cells from human plucked hair: a further step towards autologous nerve recovery. Cytotechnology. 2016;68:1849-58 pubmed publisher
  109. Yan L, Liu Y, Xiang J, Wu Q, Xu L, Luo X, et al. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer. Int J Oncol. 2016;48:471-84 pubmed publisher
  110. Werner A, Iwasaki S, McGourty C, Medina Ruiz S, Teerikorpi N, Fedrigo I, et al. Cell-fate determination by ubiquitin-dependent regulation of translation. Nature. 2015;525:523-7 pubmed publisher
  111. Luanpitpong S, Li J, Manke A, Brundage K, Ellis E, McLaughlin S, et al. SLUG is required for SOX9 stabilization and functions to promote cancer stem cells and metastasis in human lung carcinoma. Oncogene. 2016;35:2824-33 pubmed publisher
  112. Yokdang N, Hatakeyama J, Wald J, Simion C, Tellez J, Chang D, et al. LRIG1 opposes epithelial-to-mesenchymal transition and inhibits invasion of basal-like breast cancer cells. Oncogene. 2016;35:2932-47 pubmed publisher
  113. Zhao Y, Londono P, Cao Y, Sharpe E, Proenza C, O Rourke R, et al. High-efficiency reprogramming of fibroblasts into cardiomyocytes requires suppression of pro-fibrotic signalling. Nat Commun. 2015;6:8243 pubmed publisher
  114. Chiang K, Kuo S, Chen C, Ng S, Lin S, Yeh C, et al. MART-10, the vitamin D analog, is a potent drug to inhibit anaplastic thyroid cancer cell metastatic potential. Cancer Lett. 2015;369:76-85 pubmed publisher
  115. Pickup M, Hover L, Guo Y, Gorska A, Chytil A, Novitskiy S, et al. Deletion of the BMP receptor BMPR1a impairs mammary tumor formation and metastasis. Oncotarget. 2015;6:22890-904 pubmed
  116. Tsui K, Hsu S, Chung L, Lin Y, Feng T, Lee T, et al. Growth differentiation factor-15: a p53- and demethylation-upregulating gene represses cell proliferation, invasion, and tumorigenesis in bladder carcinoma cells. Sci Rep. 2015;5:12870 pubmed publisher
  117. Mego M, Cierna Z, Janega P, Karaba M, Minarik G, Benca J, et al. Relationship between circulating tumor cells and epithelial to mesenchymal transition in early breast cancer. BMC Cancer. 2015;15:533 pubmed publisher
  118. Seo G, Ho M, Bui N, Kim Y, Koh D, Lim Y, et al. Novel naphthochalcone derivative accelerate dermal wound healing through induction of epithelial-mesenchymal transition of keratinocyte. J Biomed Sci. 2015;22:47 pubmed publisher
  119. Cheung S, Boey Y, Koh V, Thike A, Lim J, Iqbal J, et al. Role of epithelial-mesenchymal transition markers in triple-negative breast cancer. Breast Cancer Res Treat. 2015;152:489-98 pubmed publisher
  120. Castillo Lluva S, Hontecillas Prieto L, Blanco Gómez A, Del Mar Sáez Freire M, García Cenador B, García Criado J, et al. A new role of SNAI2 in postlactational involution of the mammary gland links it to luminal breast cancer development. Oncogene. 2015;34:4777-90 pubmed publisher
  121. Min K, Liggett J, Silva G, Wu W, Wang R, Shen R, et al. NAG-1/GDF15 accumulates in the nucleus and modulates transcriptional regulation of the Smad pathway. Oncogene. 2016;35:377-88 pubmed publisher
  122. Li S, Wu X, Dong C, Xie X, Wu J, Zhang X. The differential expression of OCT4 isoforms in cervical carcinoma. PLoS ONE. 2015;10:e0118033 pubmed publisher
  123. Xu T, Fan B, Lv C, Xiao D. Slug mediates nasopharyngeal carcinoma radioresistance via downregulation of PUMA in a p53-dependent and -independent manner. Oncol Rep. 2015;33:2631-8 pubmed publisher
  124. Piva R, Lambertini E, Manferdini C, Capanni C, Penolazzi L, Gabusi E, et al. Slug transcription factor and nuclear Lamin B1 are upregulated in osteoarthritic chondrocytes. Osteoarthritis Cartilage. 2015;23:1226-30 pubmed publisher
  125. Knezevic J, Pfefferle A, Petrovic I, Greene S, Perou C, Rosen J. Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential. Oncogene. 2015;34:5997-6006 pubmed publisher
  126. Joseph J, Conroy S, Pavlov K, Sontakke P, Tomar T, Eggens Meijer E, et al. Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1α-ZEB1 axis. Cancer Lett. 2015;359:107-16 pubmed publisher
  127. Cheng Y, Chen P, Chiang H, Suen C, Hwang M, Lin T, et al. Candidate tumor suppressor B-cell translocation gene 3 impedes neoplastic progression by suppression of AKT. Cell Death Dis. 2015;6:e1584 pubmed publisher
  128. Satelli A, Mitra A, Brownlee Z, Xia X, Bellister S, Overman M, et al. Epithelial-mesenchymal transitioned circulating tumor cells capture for detecting tumor progression. Clin Cancer Res. 2015;21:899-906 pubmed publisher
  129. Galvagni F, Lentucci C, Neri F, Dettori D, De Clemente C, Orlandini M, et al. Snai1 promotes ESC exit from the pluripotency by direct repression of self-renewal genes. Stem Cells. 2015;33:742-50 pubmed publisher
  130. Pathania S, Bade S, Le Guillou M, Burke K, Reed R, Bowman Colin C, et al. BRCA1 haploinsufficiency for replication stress suppression in primary cells. Nat Commun. 2014;5:5496 pubmed publisher
  131. Shriver M, Stroka K, Vitolo M, Martin S, Huso D, Konstantopoulos K, et al. Loss of giant obscurins from breast epithelium promotes epithelial-to-mesenchymal transition, tumorigenicity and metastasis. Oncogene. 2015;34:4248-59 pubmed publisher
  132. Joseph J, Conroy S, Tomar T, Eggens Meijer E, Bhat K, Copray S, et al. TGF-β is an inducer of ZEB1-dependent mesenchymal transdifferentiation in glioblastoma that is associated with tumor invasion. Cell Death Dis. 2014;5:e1443 pubmed publisher
  133. Sun Y, Hu L, Zheng H, Bagnoli M, Guo Y, Rupaimoole R, et al. MiR-506 inhibits multiple targets in the epithelial-to-mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer. J Pathol. 2015;235:25-36 pubmed publisher
  134. Lee J, Chung L, Chen Y, Feng T, Juang H. N-myc downstream-regulated gene 1 downregulates cell proliferation, invasiveness, and tumorigenesis in human oral squamous cell carcinoma. Cancer Lett. 2014;355:242-52 pubmed publisher
  135. Lu G, Zhang Q, Huang Y, Song J, Tomaino R, Ehrenberger T, et al. Phosphorylation of ETS1 by Src family kinases prevents its recognition by the COP1 tumor suppressor. Cancer Cell. 2014;26:222-34 pubmed publisher
  136. Liang W, Hao Z, Han J, Zhu D, Jin Z, Xie W. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition. Urol Oncol. 2014;32:855-63 pubmed publisher
  137. Adham S, Al Harrasi I, Al Haddabi I, Al Rashdi A, Al Sinawi S, Al Maniri A, et al. Immunohistological insight into the correlation between neuropilin-1 and epithelial-mesenchymal transition markers in epithelial ovarian cancer. J Histochem Cytochem. 2014;62:619-31 pubmed publisher
  138. Subramani R, Lopez Valdez R, Arumugam A, Nandy S, Boopalan T, Lakshmanaswamy R. Targeting insulin-like growth factor 1 receptor inhibits pancreatic cancer growth and metastasis. PLoS ONE. 2014;9:e97016 pubmed publisher
  139. Kim M, Kim M, Kim H, Kim Y, Song Y. Expression profiles of epithelial-mesenchymal transition-associated proteins in epithelial ovarian carcinoma. Biomed Res Int. 2014;2014:495754 pubmed publisher
  140. Fukai J, Fujita K, Yamoto T, Sasaki T, Uematsu Y, Nakao N. Intracranial extension of adenoid cystic carcinoma: potential involvement of EphA2 expression and epithelial-mesenchymal transition in tumor metastasis: a case report. BMC Res Notes. 2014;7:131 pubmed publisher
  141. Li A, Morton J, Ma Y, Karim S, Zhou Y, Faller W, et al. Fascin is regulated by slug, promotes progression of pancreatic cancer in mice, and is associated with patient outcomes. Gastroenterology. 2014;146:1386-96.e1-17 pubmed publisher
  142. Wu K, Chen K, Wang C, Jiao X, Wang L, Zhou J, et al. Cell fate factor DACH1 represses YB-1-mediated oncogenic transcription and translation. Cancer Res. 2014;74:829-39 pubmed publisher
  143. Shintaku M, Yoneda H, Hirato J, Nagaishi M, Okabe H. Gliosarcoma with ependymal and PNET-like differentiation. Clin Neuropathol. 2013;32:508-14 pubmed publisher
  144. Devine D, Rostas J, Metge B, Das S, Mulekar M, Tucker J, et al. Loss of N-Myc interactor promotes epithelial-mesenchymal transition by activation of TGF-?/SMAD signaling. Oncogene. 2014;33:2620-8 pubmed publisher
  145. Maddaluno L, Rudini N, Cuttano R, Bravi L, Giampietro C, Corada M, et al. EndMT contributes to the onset and progression of cerebral cavernous malformations. Nature. 2013;498:492-6 pubmed publisher
  146. Chu I, Lai W, Aprelikova O, El Touny L, Kouros Mehr H, Green J. Expression of GATA3 in MDA-MB-231 triple-negative breast cancer cells induces a growth inhibitory response to TGFß. PLoS ONE. 2013;8:e61125 pubmed publisher
  147. Nagaishi M, Nobusawa S, Tanaka Y, Ikota H, Yokoo H, Nakazato Y. Slug, twist, and E-cadherin as immunohistochemical biomarkers in meningeal tumors. PLoS ONE. 2012;7:e46053 pubmed publisher
  148. Wu C, Tang S, Wang P, Lee H, Ko J. Nickel-induced epithelial-mesenchymal transition by reactive oxygen species generation and E-cadherin promoter hypermethylation. J Biol Chem. 2012;287:25292-302 pubmed publisher